ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHARD BUBB MD

Endocrinology, Diabetes Metabolism

6,536

$954K

888
653 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 47%

$146
Average prescription price

Avg: $136

DANIEL CARUSO MD

Endocrinology, Diabetes Metabolism

4,875

$782K

383
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 47%

$160
Average prescription price

Avg: $136

ROBERT FREDERICKS MD

Endocrinology, Diabetes Metabolism

4,812

$685K

341
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 47%

$142
Average prescription price

Avg: $136

AVI OSTROWSKY M.D.

Endocrinology, Diabetes Metabolism

3,783

$358K

188
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 47%

$95
Average prescription price

Avg: $136

SAMER NAKHLE MD

Endocrinology, Diabetes Metabolism

3,507

$479K

345
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 47%

$136
Average prescription price

Avg: $136

JAMES ATCHESON MD

Endocrinology, Diabetes Metabolism

3,311

$208K

308
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 47%

$63
Average prescription price

Avg: $136

FRED TOFFEL M.D.

Endocrinology, Diabetes Metabolism

2,355

$380K

226
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 47%

$161
Average prescription price

Avg: $136

FIRHAAD ISMAIL M.D.

Endocrinology, Diabetes Metabolism

2,288

$376K

293
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 47%

$164
Average prescription price

Avg: $136

WILLIAM LITCHFIELD M. D.

Endocrinology, Diabetes Metabolism

2,225

$414K

298
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 47%

$186
Average prescription price

Avg: $136

ANN OWEN MD

Endocrinology, Diabetes Metabolism

2,184

$186K

140
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 47%

$85
Average prescription price

Avg: $136

VLADIMIR PRIVMAN MD

Endocrinology, Diabetes Metabolism

2,134

$265K

238
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 47%

$124
Average prescription price

Avg: $136

MOLOUK RAHNEMA MD

Endocrinology, Diabetes Metabolism

2,012

$377K

247
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 47%

$187
Average prescription price

Avg: $136

PAUL TOMASIC

Endocrinology, Diabetes Metabolism

2,009

$345K

259
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 47%

$172
Average prescription price

Avg: $136

ROBERT ROSENQUIST M.D.

Endocrinology, Diabetes Metabolism

1,942

$216K

117
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 47%

$111
Average prescription price

Avg: $136

STANLEY SHANE M.D.

Endocrinology, Diabetes Metabolism

1,861

$169K

157
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 47%

$91
Average prescription price

Avg: $136

LISA ABBOTT MD

Endocrinology, Diabetes Metabolism

1,839

$186K

237
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

69%
prescriptions for brand name drugs

Avg: 47%

$101
Average prescription price

Avg: $136

LUBNA AHMAD M.D.

Endocrinology, Diabetes Metabolism

1,689

$193K

180
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 47%

$114
Average prescription price

Avg: $136

MARIA NWOKIKE M.D.

Endocrinology, Diabetes Metabolism

1,606

$329K

208
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 47%

$205
Average prescription price

Avg: $136

CAROL CHENEY MD

Endocrinology, Diabetes Metabolism

1,497

$244K

140
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 47%

$163
Average prescription price

Avg: $136

STEPHEN CASTORINO MD

Endocrinology, Diabetes Metabolism

1,406

$147K

100
60 are 65+

23%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 47%

$105
Average prescription price

Avg: $136

JOHN SUTTON DO

Endocrinology, Diabetes Metabolism

1,341

$217K

156
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

79%
prescriptions for brand name drugs

Avg: 47%

$162
Average prescription price

Avg: $136

QUANG NGUYEN DO

Endocrinology, Diabetes Metabolism

1,317

$125K

152
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 47%

$95
Average prescription price

Avg: $136

KENNETH IZUORA MD

Endocrinology, Diabetes Metabolism

1,289

$168K

148
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 47%

$131
Average prescription price

Avg: $136

CLAUDE LARDINOIS MD

Endocrinology, Diabetes Metabolism

1,282

$147K

140
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 47%

$115
Average prescription price

Avg: $136

FARRUKH IQBAL MD

Endocrinology, Diabetes Metabolism

1,237

$131K

146
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 47%

$106
Average prescription price

Avg: $136

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank